Skip to main navigation Skip to search Skip to main content

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination with Statin Therapy in Patients with Clincally

Project: Research

Project Details

StatusFinished
Effective start/end date08/14/1302/13/18

Funding

  • Amgen Incorporated: $62,992.72